Deproco
1 products tracked · names used in filings: Deproco
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 19 Mar 2026🇺🇸 FDA approval
FDA approves Flavalta (epinephrine bitartrate, lidocaine hydrochloride): new formulation or manufacturer
Deproco; NDA216564; New formulation or manufacturer; solution · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Flavalta epinephrine bitartrate, lidocaine hydrochloride | Approved | 2026-03-19 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.